Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OSBPL6 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | PUS7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | SMARCAD1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | COPE | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | CD300C | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | ATP1A1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | SERPINB9 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | PTGDR2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | IPO9 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ANKRA2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |